PREVIOUS PAPERS from these laboratories have reported on the efficacy of xenogeneic tumour-directed antibodies given in conjunction with cytotoxic agents in suppressing growth of the EL4 lymphoma of C57BL/6 mice (Davies & O'Neill, 1973; Davies, 1974) . This tumour was chemically induced over 30 years ago (Gorer, 1950) and there has recently been criticism of the validity or relevance of such models, especially in relation to immunotherapy (Hewitt, 1978 ning 24 h after tumour-cell injection. Each treatment consisted of i.p. injections of 0 3 mg cytosine arabinoside (Ara-C), 0 5 ml of rabbit anti-SB1 serum (absorbed with packed cells from normal mouse spleens) or both Ara-C and antiserum. In two of the experiments, Ara-C significantly increased the mean survival time. The antiserum alone caused a modest, but not statistically significant increase in survival time in all 3 experiments. However, the combination of drug and antiserum produced a highly significant inhibition of tumour development with 40, 80 and 700o of animals surviving for more than 50 days in the 3 experiments. One of the experiments (Exp. 2) had additional groups (not shown) which were treated with normal rabbit serum alone and with Ara-C. The normal serum had no effect on survival and in combination with the drug was slightly less effective than Ara-C alone (mean survival time 18-9 days, 3 survivors out of 10). In Exp. 3 an additional group of mice treated with NRS alone had a mean survival time of I 5 6 days with 2 survivors and this was not significantly different from the control group. (Peto & Pike, 1973) . These results indicate a beneficial interaction or synergism between antibodies and Ara-C similar to that previously reported for EL4. These observations could be of some importance because SB1, though a transplanted tumour, and to that extent "artificial", was of spontaneous origin in a mouse strain with a low tumour incidence, and is arguably closer in nature to "spontaneous" human tumours than are the chemically induced tumours such as EL4.
The specificity of the antibody or antibodies involved has yet to be clarified. Absorption of the antisera was carried out to eliminate toxicity (apparently associated with haemolytic activity) and the absorbed antisera still showed in vitro activity against normal BALB/c lymphocytes. However, other antisera with similar activity have failed to influence the growth of SB1, so the effects recorded here would not seem to be due to antibodies against normal BALB/c tissue, but this point should be clarified.
